Eva Nozik‐Grayck

5.4k total citations
125 papers, 3.8k citations indexed

About

Eva Nozik‐Grayck is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Eva Nozik‐Grayck has authored 125 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pulmonary and Respiratory Medicine, 36 papers in Molecular Biology and 24 papers in Physiology. Recurrent topics in Eva Nozik‐Grayck's work include Pulmonary Hypertension Research and Treatments (38 papers), Neonatal Respiratory Health Research (24 papers) and Nitric Oxide and Endothelin Effects (19 papers). Eva Nozik‐Grayck is often cited by papers focused on Pulmonary Hypertension Research and Treatments (38 papers), Neonatal Respiratory Health Research (24 papers) and Nitric Oxide and Endothelin Effects (19 papers). Eva Nozik‐Grayck collaborates with scholars based in United States, Denmark and Canada. Eva Nozik‐Grayck's co-authors include Kurt R. Stenmark, Claude A. Piantadosi, Hagir B. Suliman, Susan M. Majka, Evgenia Gerasimovskaya, Suzette Riddle, Maria G. Frid, Karim C. El Kasmi, Michael E. Yeager and Fakhrul Ahsan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Eva Nozik‐Grayck

121 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Nozik‐Grayck United States 35 1.7k 1.2k 634 632 377 125 3.8k
Roy L. Sutliff United States 40 999 0.6× 2.0k 1.6× 377 0.6× 789 1.2× 711 1.9× 104 4.2k
Tamotsu Ishizuka Japan 44 1.4k 0.8× 2.5k 2.0× 500 0.8× 953 1.5× 193 0.5× 204 5.6k
Akihide Tanimoto Japan 39 669 0.4× 1.7k 1.4× 785 1.2× 691 1.1× 427 1.1× 262 4.9k
Weiling Xu United States 30 1.8k 1.1× 1.2k 1.0× 229 0.4× 827 1.3× 586 1.6× 61 3.2k
Yunchao Su United States 36 975 0.6× 2.1k 1.7× 479 0.8× 1.2k 1.8× 545 1.4× 105 5.0k
Hong Yang China 37 1.1k 0.7× 2.0k 1.6× 1.4k 2.2× 247 0.4× 434 1.2× 227 4.8k
Yukio Ishikawa Japan 42 839 0.5× 1.1k 0.9× 1.2k 2.0× 340 0.5× 789 2.1× 107 4.2k
Cheryl L. Fattman United States 29 1.4k 0.8× 1.1k 0.9× 516 0.8× 366 0.6× 118 0.3× 38 3.5k
Koichi Sato Japan 36 1.1k 0.6× 1.4k 1.2× 774 1.2× 1.0k 1.6× 978 2.6× 204 4.4k
You‐Yang Zhao United States 37 1.5k 0.9× 2.6k 2.1× 572 0.9× 620 1.0× 1.4k 3.6× 82 5.7k

Countries citing papers authored by Eva Nozik‐Grayck

Since Specialization
Citations

This map shows the geographic impact of Eva Nozik‐Grayck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Nozik‐Grayck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Nozik‐Grayck more than expected).

Fields of papers citing papers by Eva Nozik‐Grayck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Nozik‐Grayck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Nozik‐Grayck. The network helps show where Eva Nozik‐Grayck may publish in the future.

Co-authorship network of co-authors of Eva Nozik‐Grayck

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Nozik‐Grayck. A scholar is included among the top collaborators of Eva Nozik‐Grayck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Nozik‐Grayck. Eva Nozik‐Grayck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lewis, Caitlin, Kurt R. Stenmark, Claudia Mickael, et al.. (2025). Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia. American Journal of Physiology-Lung Cellular and Molecular Physiology. 328(6). L885–L900. 1 indexed citations
2.
Harris, Peter S., Cole R. Michel, Shashikant Ray, et al.. (2025). Deacetylation of SOD3 by sirtuins restores furin cleavage. PubMed. 14. 100062–100062.
3.
Mickael, Claudia, Rubin M. Tuder, Eva Nozik‐Grayck, et al.. (2024). Activation of platelets and the complement system in mice with Schistosoma-induced pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 327(5). L661–L668. 3 indexed citations
4.
Lewis, Caitlin, et al.. (2024). Lung EC-SOD Overexpression Prevents Hypoxia-Induced Platelet Activation and Lung Platelet Accumulation. Antioxidants. 13(8). 975–975. 4 indexed citations
5.
Lewis, Caitlin, et al.. (2024). Increased Circulating Extracellular Superoxide Dismutase Attenuates Platelet–Neutrophil Interactions. American Journal of Respiratory Cell and Molecular Biology. 72(6). 653–662. 2 indexed citations
6.
Lewis, Caitlin, Anastacia M. Garcia, Kurt R. Stenmark, et al.. (2024). Redistribution of SOD3 expression due to R213G polymorphism affects pulmonary interstitial macrophage reprogramming in response to hypoxia. Physiological Genomics. 56(11). 776–790. 2 indexed citations
7.
Lewis, Caitlin, Evgenia Dobrinskikh, Frederik Denorme, et al.. (2024). Nbeal2 knockout mice are not protected against hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension. Blood Advances. 9(7). 1571–1584.
8.
Knudsen, Lars, Elayaraja Kolanthai, Sudipta Seal, et al.. (2023). CNP-miR146a improves outcomes in a two-hit acute- and ventilator-induced lung injury model. Nanomedicine Nanotechnology Biology and Medicine. 50. 102679–102679. 14 indexed citations
9.
Elajaili, Hanan, et al.. (2023). Use of Electron Paramagnetic Resonance (EPR) to Evaluate Redox Status in a Preclinical Model of Acute Lung Injury. Molecular Imaging and Biology. 26(3). 495–502. 5 indexed citations
10.
Roy, René M., Ayed Allawzi, Nana Burns, et al.. (2023). Lactate produced by alveolar type II cells suppresses inflammatory alveolar macrophages in acute lung injury. The FASEB Journal. 37(12). e23316–e23316. 14 indexed citations
11.
Lewis, Caitlin, Nana Burns, K. Oshima, et al.. (2023). Release of extracellular superoxide dismutase into alveolar fluid protects against acute lung injury and inflammation in Staphylococcus aureus pneumonia. American Journal of Physiology-Lung Cellular and Molecular Physiology. 324(4). L445–L455. 9 indexed citations
12.
Leinwand, Leslie A., et al.. (2023). Breath analysis by ultra-sensitive broadband laser spectroscopy detects SARS-CoV-2 infection. Journal of Breath Research. 17(3). 36001–36001. 18 indexed citations
13.
Tseng, Victor, Scott D. Collum, Ayed Allawzi, et al.. (2022). 3’UTR shortening of HAS2 promotes hyaluronan hyper-synthesis and bioenergetic dysfunction in pulmonary hypertension. Matrix Biology. 111. 53–75. 6 indexed citations
14.
Elajaili, Hanan, et al.. (2022). Metabolism, Mitochondrial Dysfunction, and Redox Homeostasis in Pulmonary Hypertension. Antioxidants. 11(2). 428–428. 24 indexed citations
15.
Vohwinkel, Christine U., Nana Burns, Xiaoyi Yuan, et al.. (2022). HIF1A-dependent induction of alveolar epithelial PFKFB3 dampens acute lung injury. JCI Insight. 7(24). 17 indexed citations
16.
Vohwinkel, Christine U., Nana Burns, Hanan Elajaili, et al.. (2021). Targeting alveolar‐specific succinate dehydrogenase A attenuates pulmonary inflammation during acute lung injury. The FASEB Journal. 35(4). e21468–e21468. 27 indexed citations
17.
Al‐Hilal, Taslim A., Ali Keshavarz, Hossam Kadry, et al.. (2020). Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application. Lab on a Chip. 20(18). 3334–3345. 28 indexed citations
18.
Kasmi, Karim C. El, Padade M. Vue, Aimee L. Anderson, et al.. (2018). Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis. Nature Communications. 9(1). 1393–1393. 78 indexed citations
19.
Suliman, Hagir B., et al.. (2004). Discordant Extracellular Superoxide Dismutase Expression and Activity in Neonatal Hyperoxic Lung. American Journal of Respiratory and Critical Care Medicine. 170(3). 313–318. 35 indexed citations
20.
Ahmed, Mohamed N., Hagir B. Suliman, Rodney J. Folz, et al.. (2003). Extracellular Superoxide Dismutase Protects Lung Development in Hyperoxia-exposed Newborn Mice. American Journal of Respiratory and Critical Care Medicine. 167(3). 400–405. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roy L. Sutliff Breakdown of academic impact, for papers by Tamotsu Ishizuka Breakdown of academic impact, for papers by Akihide Tanimoto Breakdown of academic impact, for papers by Weiling Xu Breakdown of academic impact, for papers by Yunchao Su Breakdown of academic impact, for papers by Hong Yang Breakdown of academic impact, for papers by Yukio Ishikawa Breakdown of academic impact, for papers by Cheryl L. Fattman Breakdown of academic impact, for papers by Koichi Sato Breakdown of academic impact, for papers by You‐Yang Zhao
Rankless by CCL
2026